July 29, 2015
Histogenics (HSGX) Q2 financial results on 8/12 at 8:30 a.m. ET
July 27, 2015
RegMed’s close: the sector’s fireworks went off on the hour – keep checking the shopping list for the impending reverse
July 26, 2015
RegMed weekend wrap-up: why should we care what happened last week? It’s a set-up for next week!
July 22, 2015
RegMed’s close: drifting higher but, still whacked around
July 18, 2015
RegMed weekend wrap-up: a ladder is needed to climb up and down the tape
July 15, 2015
RegMed’s close, transitory influences and factors also hit here
July 15, 2015
Histogenics (HSGX) appoints CMO
July 14, 2015
Lower to mixed open expected; RegMed, turn-up the volume
July 13, 2015
RegMed, a lot of moves on low volume but, do they have legs?
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.